EHC vs CHE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EHC Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Encompass Health Corporation Common Stock (EHC) driven by superior Valuation, Options & Structure while CHE counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, EHC trades at 19.4x Forward P/E with 18.4% operating margin (+8.9% YoY revenue) versus CHE at 19.7x Forward P/E and 14.3% operating margin (+10.6% YoY). In options structure, EHC sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against CHE sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EHC | CHE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $13.0B | $7.1B | Larger Scale | EHC |
| Trailing P/E Ratio Valuation | 21.2x | 26.4x | Lower Multiple | EHC |
| Forward P/E Ratio Valuation | 19.4x | 19.7x | Lower Multiple | EHC |
| Revenue Growth (YoY) Growth | +8.9% | +10.6% | Higher Growth | CHE |
| Operating Margin (TTM) Profitability | 18.4% | 14.3% | Higher Margin | EHC |
| Net Profit Margin Profitability | 10.2% | 10.6% | Higher Margin | CHE |
| Return on Equity (ROE) Capital Efficiency | 25.1% | 29.1% | Higher ROE | CHE |
| 52-Week Range Position Momentum | 80% ($93โ$144) | 93% ($365โ$562) | Stronger Trend | CHE |
| Beta / 30D Volatility Risk Regime | -0.10ฮฒ ยท 40% Vol | 0.11ฮฒ ยท 26% Vol | Lower Realized Risk | CHE |
| Unified Institutional Score Composite Signal | 52.0 / 100 (HOLD) | 43.8 / 100 (HOLD) | Higher Composite | EHC |